TrialBMJ open2021

Human papillomavirus vaccine efficacy against invasive, HPV-positive cancers: population-based follow-up of a cluster-randomised trial.

Matti Lehtinen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.